Chemopreventive effects of grape seed proanthocyanidin extract on Chang liver cells

Citation
Ss. Joshi et al., Chemopreventive effects of grape seed proanthocyanidin extract on Chang liver cells, TOXICOLOGY, 155(1-3), 2000, pp. 83-90
Citations number
27
Categorie Soggetti
Pharmacology & Toxicology
Journal title
TOXICOLOGY
ISSN journal
0300483X → ACNP
Volume
155
Issue
1-3
Year of publication
2000
Pages
83 - 90
Database
ISI
SICI code
0300-483X(20001130)155:1-3<83:CEOGSP>2.0.ZU;2-O
Abstract
In an attempt to ameliorate the chemotherapy associated normal cell toxicit y, in this study a known antioxidant, grape seed proanthocyanidin extract ( GSPE) using Chang liver cells has been used. Chang liver cells were treated in vitro with idarubicin (Ida) (30 nM) and 4-hydroxyperoxycyclophosphamide (4-HC) (1 mug/ml) with or without proanthocyanidin (25 mug/ml). The cells were grown in vitro and the growth rate of the cells were determined using MTT assay. The results showed that the GSPE decreased growth inhibitory eff ects of Ida and 4-HC on Chang liver cells in vitro. Since these chemotherap eutic agents are known to induce apoptosis in the target cells, these cells were also analyzed for presence of apoptotic cells using flow cytometry. T he GSPE decreased the number of apoptotic cell population induced by either chemotherapy. In an attempt to determine the mechanisms of ameliorating ef fects of proanthocyanidin, the expression of apoptosis/cell cycle/growth re lated genes, Bcl-2, p53 and c-myc was determined in the treated and control cells using Western blotting or reverse transcriptase-polymerase chain rea ction (RT-PCR) techniques. There was an increased expression of Bcl-2 in th e cells treated with GSPE. However, there was a significant decrease in the expression of other cell cycle related genes such as p53 and c-myc in thes e cells following treatment with GSPE. Thus, these results indicate that pr oanthocyanidin can be a potential candidate to ameliorate the toxic effects associated with chemotherapeutic agents used in treatment of cancer. (C) 2 000 Elsevier Science Ireland Ltd. All rights reserved.